Pharmaceuticals
US claims $3.3 bn in Novartis kickback lawsuit
01 Jul 2015
Novartis is accused of referring patients to specialty pharmacies and paying kickbacks in the form of rebates to get them to recommend the drugs to patients to boost sales
Novartis to buy chronic pain drug developer Spinifex Pharmaceuticals
29 Jun 2015
Founded in 2005 and based in Stamford, Connecticut, USA, and Melbourne, Australia, Spinifex’ lead product is EMA401, under development as a potential first-in-class oral treatment for chronic pain without CNS side effects

